| Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States | | |
| Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma | | |
| Financial toxicity in ovarian cancer | | |
| Extra-abdominal Lymph Node Metastases as the First Presentation in Ovarian and Fallopian Tube Carcinomas | | |
| Recent Advances in Classification and Histopathological Diagnosis of Ovarian Epithelial Malignant Tumours | | |
| A prospective cross-sectional survey comparing patient and provider expectations regarding ovarian cancer prognosis | Gynecologic Oncology Reports | 2022 |
| Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer | International Journal of Gynecological Cancer | |
| Hypoxia-induced inhibin promotes tumor growth and vascular permeability in ovarian cancers | Communications Biology | 2022 |
| Potential roles of claudin-3 and claudin-4 in ovarian cancer management | Journal of the Egyptian National Cancer Institute | 2022 |
| Metastasis in gynecological cancers | | 2022 |
| Perceptions and care Recommendations from Previvors: Qualitative analysis of female BRCA1/2 mutation Carriers' experience with genetic testing and counseling. | Gynecologic Oncology Reports | 2022 |
| Climacteric symptoms in postoperative patients among endometrial cancer, cervical cancer, and ovarian cancer: a cross-sectional study. | Supportive Care in Cancer | 2022 |
| Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma. | Journal of Ovarian Research | 2022 |
| Salpingo-Oophorectomy or Surveillance for Ovarian Endometrioma in Asymptomatic Premenopausal Women: a Cost-Effectiveness Analysis. | American Journal of Obstetrics and Gynecology | 2022 |
| Data_Sheet_1.pdf | | 2019 |
| Table_4.XLSX | | 2020 |
| Table_3.XLSX | | 2020 |
| Table_2.XLSX | | 2020 |
| Table_1.xlsx | | 2020 |
| Data_Sheet_3.PDF | | 2020 |
| Data_Sheet_2.PDF | | 2020 |
| Data_Sheet_1.PDF | | 2020 |
| Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience. | Annals of Surgical Oncology | 2022 |
| Prevalence of BRCA1 and BRCA2 pathogenic sequence variants in ovarian cancer patients in the Gulf region: the PREDICT study. | BMC Cancer | 2021 |
| Trends in extent of surgical cytoreduction for patients with ovarian cancer | PLoS ONE | 2021 |
| Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study. | Journal of Obstetrics and Gynaecology Research | 2021 |
| Oncologic outcomes of fertility-sparing surgery in early stage epithelial ovarian cancer: a population-based propensity score-matched analysis. | Archives of Gynecology and Obstetrics | 2022 |
| Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer. | Advances in Therapy | 2022 |
| Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact. | European Journal of Obstetrics, Gynecology and Reproductive Biology | 2022 |
| CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy. | Npj Systems Biology and Applications | 2022 |
| Aktuelle Aspekte zur operativen Therapie des primären Ovarialkarzinoms | Der Gynakologe | 2022 |
| Ovarian Carcinoma Presenting With a Large Cervical Mass. | Cureus | 2022 |
| Sensitive New Assay System for Serum Agglutinin-Reactive Ceruloplasmin That Distinguishes Ovarian Clear Cell Carcinoma from Endometrioma. | Analytical Chemistry | 2022 |
| An integrated approach to protein discovery and detection from complex biofluids | | |
| Breast cancer risk in mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer. | Gynecologic Oncology Reports | 2022 |
| Extracellular Vesicle Molecular Signatures Characterize Metastatic Dynamicity in Ovarian Cancer | Frontiers in Oncology | 2021 |
| Estimating the Financial Impact of Gene Therapy* | | |
| Tumors of the Female Reproductive Organs | | 2020 |
| Gynecologic Disorders in the Older Woman | | 2020 |
| Over kanserinin epidemiyolojisi ve genel sağ kalım özellikleri | Ege Tıp Dergisi | |
| Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program | Advances in Therapy | 2021 |
| Pretreatment with LCK Inhibitors Chemosensitizes Cisplatin-Resistant Endometrioid Ovarian Tumors | | |
| Adnexal Masses in Adolescents | Pediatric Annals | 2020 |
| Supervivencia de pacientes con cáncer epitelial de ovario en el Instituto Nacional de Cancerología, resultados a partir del registro hospitalario de cáncer, (2005-2014) | Revista Colombiana De Cancerología | 2019 |
| The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma | | |
| Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4 | International Journal of Gynecological Cancer | 2019 |
| Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer | World Journal of Clinical Oncology | 2019 |
| Cancers | Advances in Bioinformatics and Biomedical Engineering Book Series | 2019 |
| Gynecologic Disorders in the Older Woman | | 2019 |
| Epithelial Tumors of the Ovary | | 2018 |
